IP Library Granted Patent US 11,623,079
Granted Patent B2
US 11,623,079 · App. 17/461,886 · Granted Apr 11, 2023

Vagal nerve stimulation devices and methods for treating medical conditions

Inventors: Bruce J. Simon (Mountain Lakes, NJ); Joseph P. Errico (Palm Beach Gardens, FL); John T. Raffle (Austin, TX)
Assignee: ELECTROCORE, INC
A61N1/0456A61N1/36014A61N1/36021A61N1/36034A61N1/36053A61N1/40A61N2/008A61N2/02H04R25/305H04R25/505H04R25/70A61N1/36075A61N2/006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,623,079
App. No.
17/461,886
Granted
Apr 11, 2023
Kind
B2
Abstract

Vagal nerve stimulation devices and methods are provided for treating medical conditions, such as conditions associated with insufficient dopamine and/or endogenous opioids in the brain. A device includes one or more electrodes having a contact surface for contacting an outer skin surface of a patient and an energy source coupled to the electrodes. The energy source generates one or more electrical impulses and transmits the electrical impulses to the electrodes and transcutaneously through the outer skin surface of the patient at or near a vagus nerve. The one or more electrical impulses is sufficient to modulate the vagus nerve and release dopamine and/or endogenous opioids in a brain of the patient.

Claims (12)

1. A method for treating addiction in a patient the method comprising:

positioning one or more electrodes in contact with an outer skin surface of a neck of the patient;

generating one or more electrical impulses; and

transmitting the one or more electrical impulses to the one or more electrodes transcutaneously through the outer skin surface of the patient at or near a vagus nerve within the patient, wherein the one or more electrical impulses is sufficient to modulate the vagus nerve and release dopamine and GABA and to produce endogenous opioids or endogenous cannabinoids in a brain of the patient.

2. The method of claim 1 , wherein the one or more electrical impulses are generated within a housing and transmitted to the one or more electrodes within the housing.

3. The method of claim 1 , wherein the one or more electrical impulses is sufficient to modulate activity of the vagus nerve to release one or more inhibitory neurotransmitters within the brain of the patient.

4. The method of claim 1 , wherein the one or more electrical impulses is sufficient to modulate activity of the vagus nerve to stimulate one or more dopamine-producing neurons in the brain of the patient.

5. The method of claim 1 , wherein the endogenous opioids generate euphoria within the patient.

6. The method of claim 1 , wherein the one or more electrical impulses is generated by further a signal generator, wherein the one or more electrical pulses comprises bursts of 2 to 20 pulses within each burst, wherein each burst has a frequency of about 5 Hz to about 100 Hz.

7. The method of claim 6 , wherein each burst of pulses comprises a burst period and a constant period, wherein each burst period and constant period together have a combined frequency from about 15 Hz to about 50 Hz, and, wherein the pulses alternate between a positive voltage and a negative voltage within each of the burst periods.

8. The method of claim 7 , further comprising generating zero pulses during the constant periods.

9. The method of claim 6 , wherein each pulse has a duration of about 20 to about 1000 microseconds.

Assignments (2)
SECURITY INTEREST Recorded Aug 12, 2025
From: ELECTROCORE, INC.
To: AVENUE VENTURE OPPORTUNITIES FUND II, L.P.
Reel/Frame 072452/0559 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 30, 2021
From: ELECTROCORE, LLC
To: ELECTROCORE, INC
Reel/Frame 057333/0132 →
Continuity (23)
Continuation 16540435 · Aug 14, 2019
Division 14992921 · Jan 11, 2016
Continuation 14229894 · Mar 29, 2014
Division 13109250 · May 17, 2011
Continuation In Part 13075746 · Mar 30, 2011
Continuation In Part 13024727 · Feb 10, 2011
Continuation In Part 13005005 · Jan 12, 2011
Continuation In Part 12964050 · Dec 9, 2010
Continuation In Part 12859568 · Aug 19, 2010
Continuation In Part 12612177 · Nov 4, 2009
Continuation In Part 12408131 · Mar 20, 2009
Continuation In Part 11592095 · Nov 2, 2006
Continuation In Part 11591340 · Nov 1, 2006
Provisional Application 61471405 · Apr 4, 2011
Provisional Application 61451259 · Mar 10, 2011
Provisional Application 61415469 · Nov 19, 2010
Provisional Application 60814312 · Jun 16, 2006
Provisional Application 60814313 · Jun 16, 2006
Provisional Application 60786564 · Mar 28, 2006
Provisional Application 60772361 · Feb 10, 2006
Provisional Application 60736002 · Nov 10, 2005
Provisional Application 60736001 · Nov 10, 2005
Related Publication 20210392447A1 · Dec 16, 2021
Cited By (3)
US 12,543,961 US 12,594,026 US 12,642,486